27-28 May 2026
Sanofi Campus Gentilly

3rd Edition

Program will be added once finalised.
Check the program of the previous edition HERE

PROGRAM

DAY 1

Wednesday, 27 May 2026

8h15

Welcome coffee and registration

8h45

Welcome address

- Plenary

Chairman

Yves Jacob

R&D Lead France

Sanofi - France

Yves Jacob

R&D Lead France

Sanofi - France

Yves Jacob

R&D Lead France

Sanofi - France

9h15

Keynote lecture

- Plenary

Chairman

9h15

To be determined

Prénom Nom

Mettre à jour le poste

Entreprise - Pays

9h45

Track 1: Next-Generation RNA Therapies: From mRNA to Circular RNA

- Plenary

Chairman

9h45

Title to be confirmed​

Alexandre Hill

CEO

Serendip Innovations - France

10h05

Precise genome engineering : Next-generation virus-like particle platforms for CRISPR-Cas9 delivery in primary cells

Philippe Mangeot

Researcher

(CIRI) International Center for Infectiology Research - France

10h25

Converting a Hematopoietic Mutation into a Therapeutic Cytotoxic Payload via mRNA-LNP Delivery

Chantal Lagresle

Researcher

Imagine Institute - France

10h45

Q&A Session

11h00

Coffee break - Exhibition Hall

11h30

Roundtable

- Plenary

Animated by MabDesign

Prénom Nom

Mettre à jour le poste

Entreprise -Pays

12h15

Lunch - Exhibition Hall - B2B Meetings

14h00

Keynote lecture

- Plenary

Chairman

14h00

Advancing In Vivo RNA Therapies Towards Clinical in B Cell Mediated Autoimmune Diseases

Gilles Besin

Head of RNA and in vivo CAR

Bristol-Myers Squibb - USA

14h30

Track 2: Exploring the Future of CARs (ex vivo & in vivo)

- Plenary

Chairman

14h30

From Vein-to-Vein to On-Demand: Redefining CAR Manufacturing

Carmen Sanges

Executive Board Member

T2EVOLVE - Germany

14h50

Metabolically Programmed Hyper-Targeting Pluripotent Stem Cell Derived Natural Killer Cells for Adoptive Cell Immunotherapy

Niels-Bjarne Woods

Associate Professor, Section Molecular Medicine and Gene Therapy

Lund University - Sweden

15h10

Allogeneic T Cell Precursors: Toward a True Off-the-Shelf T Cell Immunotherapy

Inna Menkova

CEO

Allogenica - France

15h30

Q&A Session

15h40

Short break

15h45

Workshops

Workshop #1

Prénom Nom

Mettre à jour le poste

Entreprise - Pays

Marc Meichenin

Chief Scientific Officer

Clean Cells - France

Guillaume Sirgue

Director Technical Excellence

Oxford Biomedica - France

Christelle Rochon

Head of Strategic partnerships
and BD /CMC consultant

INITS - France

Workshop #2

Prénom Nom

Mettre à jour le poste

Entreprise - Pays

16h30

Coffe Break - Exhibition Hall - B2B Meetings

17h00

Breakthrough innovation session

- Plenary

Chairman

17h00

Beyond Averages: Direct Mass Analysis of Viral Vectors Using CDMS

Ben Wilkes

Principal Biologics Market Development Manager

Waters - United Kingdom

17h15

Sponsor Slot

Prénom Nom

Mettre à jour le poste

Entreprise - Pays

17h30

Pitch 1

Prénom Nom

Mettre à jour le poste

Entreprise - Pays

17h40

Pitch 2

Prénom Nom

Mettre à jour le poste

Entreprise - Pays

17h50

Pitch 3

Prénom Nom

Mettre à jour le poste

Entreprise - Pays

18h00

Pitch 4

Prénom Nom

Mettre à jour le poste

Entreprise - Pays

18h10

Pitch 5

Prénom Nom

Mettre à jour le poste

Entreprise - Pays

18h20

Pitch 6

Prénom Nom

Mettre à jour le poste

Entreprise - Pays

18h30

Cocktail Reception hosted by Sanofi

19h45

End of day 1